NovoCure Ltd — Director's Dealing 2019

Jan 11, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2019-01-09

Reporting Person: LEUNG GABRIEL (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-01-09	Ordinary Shares	M	20000	$3.44	Acquired	80000	Direct
2019-01-09	Ordinary Shares	S	13274	$40.00	Disposed	66726	Direct
2019-01-09	Ordinary Shares	S	6726	$40.01	Disposed	60000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-01-09	Options to Buy Ordinary Shares	$3.44	M	20000	Acquired	2021-09-14	Ordinary Shares (20000)	Direct

Footnotes

F1: These shares were acquired pursuant to a Rule 10b5-1 trading plan adopted by Mr. Leung.

F2: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Leung.

F3: Fully vested as of the date hereof.